Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mansmed: Metformin in Advanced Prostate Cancer
NCT03137186Phase 2Unknown
- Sponsor
- Mansoura University
- Start
- Jan 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of metformin in prostate cancer (PCa) (2 arms), sponsored by Mansoura University. Primary endpoint: Duration from beginning of treatment till development of CRPC at 2 years. Status: unknown.
02
Drugs
metformin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03137186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137186.